Share
Journal Information
Issue
Vol. 15. Issue 6.Pages 812-1033 (November - December 2016)
Hepatology highlights
Editorial
Concise review
Treatment of chronic HBV infection in developing countries
Rosa Zampino, Caterina Sagnelli, Adriana Boemio, Evangelista Sagnelli, Nicola Coppola
Ann Hepatol. 2016;15:816-23
Open access
Original article
PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus
Ahmed A. Al-Qahtani, Mashael R. Al-Anazi, Fahad A. Al-Zoghaibi, Ayman A. Abdo, Faisal M. Sanai, Waleed K. Al-Hamoudi, Khalid A. Alswat, Hamad I. Al-Ashgar, ... Mohammed N. Al-Ahdal
Ann Hepatol. 2016;15:824-33
Open access
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection
Maribel Rodriguez-Torres, Eric Läwitz, Bienvenido Yangco, Lennox Jeffers, Steven-Huy Han, Paul J. Thuluvath, Vinod Rustgi, Stephen Harrison, ... Michelle Treitel
Ann Hepatol. 2016;15:834-45
Open access
Frequency of hepatitis C virus infection in a single institution in Mexico with a focus on birth-cohort population
Héctor Baptista-González, Victor M. Noffal-Nuño, Nahum Méndez-Sánchez
Ann Hepatol. 2016;15:846-52
Open access
Most overweight and obese Indian children have nonalcoholic fatty liver disease
Sunil V. Pawar, Vinay G. Zanwar, Ajay S. Choksey, Ashok R. Mohite, Samit S. Jain, Ravindra G. Surude, Qais Q. Contractor, Pravin M. Rathi, ... Premlata K. Varthakavi
Ann Hepatol. 2016;15:853-61
Open access
Chemerin, retinol binding protein-4, cytokeratin-18 and transgelin-2 presence in sera of patients with non-alcoholic liver fatty disease
Agnieszka Zwolak, Agnieszka Szuster-Ciesielska, Jadwiga Daniluk, Justyna Semeniuk, Martyna Kandefer-Szerszeń
Ann Hepatol. 2016;15:862-9
Open access
Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection
Kristopher P. Croome, David D. Lee, Justin M. Burns, Dana K. Perry, Justin H. Nguyen, Andrew P. Keaveny, Hani M. Wadei, C. Burcin Taner
Ann Hepatol. 2016;15:870-80
Open access
Predictive role BLVRA mRNA expression in hepatocellular cancer
Kristýna Kubícková, Iva Subhanová, Renáta Konícková, Linda Matousová, Petr Urbánek, Hana Parobková, Martin Kupec, Jirí Pudil, Libor Vítek
Ann Hepatol. 2016;15:881-7
Open access
High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation
Jigesh A. Shah, Madhukar S. Patel, Johannes R. Kratz, James F. Markmann, Parsia A. Vagefi
Ann Hepatol. 2016;15:888-94
Open access
Validation of prognostic scores for clinical outcomes in cirrhotic patients with acute variceal bleeding
Miguel Motola-Kuba, Angélica Escobedo-Arzate, Félix Tellez-Avila, José Altamirano, Nancy Aguilar-Olivos, Alberto González-Angulo, Felipe Zamarripa-Dorsey, Misael Uribe, Norberto C. Chávez-Tapia
Ann Hepatol. 2016;15:895-901
Open access
Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?
Omar D. Borjas-Almaguer, Carlos A. Cortez-Hernández, Emmanuel I. González-Moreno, Francisco J. Bosques-Padilla, José A. González-González, Aldo A. Garza, Juan A. Martínez-Segura, Diego García-Compean, ... Héctor J. Maldonado-Garza
Ann Hepatol. 2016;15:902-6
Open access
GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis
Alexander Levstik, Alan Stuart, Paul C. Adams
Ann Hepatol. 2016;15:907-10
Open access
Percutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study
Bart De Keyzer, Frederik Nevens, Annouschka Laenen, Sam Heye, Wim Laleman, Chris Verslype, Schalk van der Merwe, Geert Maleux
Ann Hepatol. 2016;15:911-7
Open access
MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4
Shanfei Ge, Lunli Zhang, Jianping Xie, Fei Liu, Jinni He, Jinwen He, Xiaowei Wang, Tianxing Xiang
Ann Hepatol. 2016;15:918-28
Open access
Images in hepatology
Pedunculated hepatic focal nodular hyperplasia
Abdel-Rauf Zeina, Yair Glick
Ann Hepatol. 2016;15:929-31
Open access
Case report
Hepatoportal sclerosis related to the use of herbal and nutritional supplements. Causality or coincidence?
Fernanda Ferreira Rios, Luiz Antônio Rodrigues de Freitas, Liana Codes, Genario Oliveira Santos Junior, Maria Isabel Schinoni, Raymundo Paraná
Ann Hepatol. 2016;15:932-8
Open access
Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis
Francia C. Díaz, Esteban Sáez-González, Salvador Benlloch, Diego Álvarez-Sotomayor, Isabel Conde, Begoña Polo, María García, María Rodríguez, Martín Prieto
Ann Hepatol. 2016;15:939-43
Open access
Letter to editor
Estimated time from clinical presentation to the development of cirrhosis in non-cirrhotic adult patients with non-alcoholic fatty liver disease
Gerald Y. Minuk, Jessica Sanders, Meaghan O’Brien, Julia Uhanova
Ann Hepatol. 2016;15:944-5
Open access
Usefulness of acoustic radiation force impulse in liver fibrosis assessment after liver transplant
Veysel Özalper, Coskun Ozturker, Guner Sonmez
Ann Hepatol. 2016;15:946
Open access
Reply to the letter to the Editor
Sara Bignulin, Edmondo Falleti, Sara Cmet, Dario Cappello, Annarosa Cussigh, Ilaria Lenisa, Denis Dissegna, Fabio Pugliese, ... Pierluigi Toniutto
Ann Hepatol. 2016;15:947-8
Open access
Liver news elsewhere
The effect of ursodeoxycholic acid in cystic cholangiopathies
Frank Lammert, Nahum Méndez-Sánchez
Ann Hepatol. 2016;15:949-50
Open access
Special notice
Abstract section
XXIV Annual Meeting of the Latin American Association for the Study of the Liver. Abstract Section. Oral Presentations
Ann Hepatol. 2016;15:953-82
Open access
XXIV Annual Meeting of the Latin American Association for the Study of the Liver. Abstract Section. Poster Presentations
Ann Hepatol. 2016;15:983-1022
Open access
Index to volume
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
